Table 5.
Variability in risk stratification across pediatric Hodgkin lymphoma clinical trials consortia
| Risk | IA | IB | IIA | IIB | IIIA | IIIB | IVA | IVB | |
|---|---|---|---|---|---|---|---|---|---|
| EuroNet C1 | Low | ||||||||
| Int | E | E | E | ||||||
| High | E | E | |||||||
|
| |||||||||
| COG | Low | ||||||||
| Int | E X |
E X |
|||||||
| High | |||||||||
|
| |||||||||
| St Jude Stanford DFCI | Low | ||||||||
| Int | E mX |
E mX >2 |
|||||||
| High | |||||||||
Abbreviations: E, extranodal extension; Int, intermediate; mX, mediastinal bulk; X, bulky disease (peripheral >6 cm and mediastinal).